Literature DB >> 2059813

Chylothorax after oesophagectomy.

C Bolger1, T N Walsh, W A Tanner, P Keeling, T P Hennessy.   

Abstract

Chylothorax is an uncommon complication of oesophagectomy. In a review of 537 oesophageal resections there were 11 cases of chylothorax, an incidence of 2.0 per cent. There was no correlation with site, size, penetration, lymph node status, length or type of tumour but there was a significant correlation between chylothorax and the type of operative procedure carried out. The incidence in 95 transhiatal resections was 10.5 per cent. The incidence following 442 transthoracic procedures was 0.2 per cent (P less than 0.001) with one chylous fistula occurring after a three-stage oesophagectomy. Initial management was conservative with chest drainage and total parenteral nutrition. Thoracotomy and duct ligation was subsequently carried out in three patients and was successful in two. The third patient died. Conservative management alone was successful in four out of eight patients, with closure of the fistula at a median of 35 days (range 14-42 days). Four patients treated conservatively died. Transhiatal oesophagectomy greatly increases the risk of chylothorax, a condition that carries a high mortality rate (46 per cent in this series) whether managed conservatively or by surgical intervention.

Entities:  

Mesh:

Year:  1991        PMID: 2059813     DOI: 10.1002/bjs.1800780521

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  36 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

3.  Blood patch treatment of chylothorax following transthoracic oesophagogastrectomy: a novel technique to aid surgical management.

Authors:  R A J Windhaber; A G Holbrook; R J Krysztopik
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

Review 4.  The thoracic duct: clinical importance, anatomic variation, imaging, and embolization.

Authors:  Oren W Johnson; Jeffrey Forris Beecham Chick; Nikunj Rashmikant Chauhan; Alexandra Holmsen Fairchild; Chieh-Min Fan; Michael S Stecker; Timothy P Killoran; Alisa Suzuki-Han
Journal:  Eur Radiol       Date:  2015-12-01       Impact factor: 5.315

Review 5.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

6.  Ligation of the thoracic duct without thoracotomy as an effective treatment for postoperative chylothorax: a newly designed surgical procedure.

Authors:  D Fan; K Liu; Q S Cheng
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 7.  Percutaneous treatment of thoracic duct injuries.

Authors:  Francesca Marcon; Katayun Irani; Theresa Aquino; John K Saunders; Thomas H Gouge; Marcovalerio Melis
Journal:  Surg Endosc       Date:  2011-05-17       Impact factor: 4.584

Review 8.  Nutritional management in patients with chyle leakage: a systematic review.

Authors:  B R Steven; S Carey
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

Review 9.  A personal perspective on controversies in the surgical management of oesophageal cancer.

Authors:  J McK Manson; W D Beasley
Journal:  Ann R Coll Surg Engl       Date:  2014-11       Impact factor: 1.891

10.  Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax-a case report.

Authors:  Yi-Chien Chang; Yi-Ting Yen; Ming-Chung Chang; Yau-Lin Tseng
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.